Table 1. Unilateral thoracoscopic surgery with postoperative outcomes at 1- 6 months

Author (measurements)No. patientsTechniquesDyspnea Scale Borg/MMRCFEV1 FVCDLCO mL/min/mm HgPO2 mm HgMortality
Little(38) (3 months)
Unilateral thoracoscopic:
YAG laser
7.6/3.6 a
62/2.9 b
(32)
0.74 L a
0.85 L b
(28)
1.82 L a
2.2 L b
(28)
10.3 a
13.7 b
(10)
59.3 a
63.3 b
(22)
5.5% (operative)
Brenner(56) (1-3 months)
24
Unilateral thoracoscopic:
C02 laser
NR
0.82 L a
1.18 L b
(19)
2.18 L a
2.96 L b
(19)
8.13 a
8.27 b
(19)
NR
12% (peri-operative)
McKenna(59) (6 months)
72
Unilateral thoracoscopic:
YAG laser
(33)
Staples
(39)
24% improved more than one grade b

66% improved more than one grade b
13.4% improvement b

32.9% improvement b
(72)

6% increase b

21% increase b
(72)
NR
NR
11% (within 3 months)
Wakabayashi(58) (3-6 months)
443
Unilateral thoracoscopic:
YAG laser
87.4% improved b
(191)
23.6% of predicted a

31.0% of predicted b
(202)
55.8% of predicted

67.4% of predicted
(203)
23.6% of predicted a

33.7% of predicted b
(123)

65.0 a

66.0 b
(96)
4.8% (operative)

a Preoperative.

b Postoperative.

Abbreviations: DLCO = carbon monoxide diffusing capacity of the lungs; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; MMRC = modified medical research council scale; NR = not reported; PO2 = partial pressure of oxygen; YAG = yttrium-argon-garnet laser.

Number in parentheses = number of patients.

From: Lung-Volume Reduction Surgery for End-Stage Chronic Obstructive Pulmonary Disease

Cover of AHCPR Health Technology Assessments
AHCPR Health Technology Assessments.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.